Form 4: Myriad Genetics Chief Scientific Officer Reports Stock Transactions
SEC Form 4 Filing
Dale Muzzey, Chief Scientific Officer of Myriad Genetics, reports the withholding of shares to cover tax obligations related to vesting restricted stock units.
Summary
- Dale Muzzey, the Chief Scientific Officer of Myriad Genetics, filed a Form 4 detailing changes in beneficial ownership.
- The report indicates that shares of common stock were withheld by the company to satisfy tax withholding obligations related to the vesting of restricted stock units.
- On March 22, 2024, 1,405 shares were withheld at a price of $22.24.
- On March 24, 2024, 382 shares were withheld at a price of $22.24.
- On March 24, 2024, 561 shares were withheld at a price of $22.24.
- Following these transactions, Muzzey directly owns 111,053 shares of Myriad Genetics common stock.
Sentiment
Score: 5
Explanation: This is a routine filing related to tax obligations, so the sentiment is neutral.
Industry Context
Form 4 filings are a routine part of compliance for company insiders and provide transparency into their transactions in the company's stock.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect routine tax-related stock adjustments.
Key Dates
| Date | Description |
|---|---|
| 03/22/2024 | 1,405 shares withheld to satisfy tax obligations at $22.24. |
| 03/24/2024 | 382 shares withheld to satisfy tax obligations at $22.24. |
| 03/24/2024 | 561 shares withheld to satisfy tax obligations at $22.24. |
| 03/25/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.